Mahmoud Fatahi Yar

Array ( [id] => 13396289 [patent_doc_number] => 20180249687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => TRANSGENIC ANIMAL FOR PRODUCTION OF ANTIBODIES HAVING A COMMON LIGHT CHAIN [patent_app_type] => utility [patent_app_number] => 15/753938 [patent_app_country] => US [patent_app_date] => 2016-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11311959 [patent_doc_number] => 20160348069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'MESENDODERM AND MESODERM CELL POPULATIONS' [patent_app_type] => utility [patent_app_number] => 15/237079 [patent_app_country] => US [patent_app_date] => 2016-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 14020 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13357821 [patent_doc_number] => 20180230450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => Cas9 Genome Editing and Transcriptional Regulation [patent_app_type] => utility [patent_app_number] => 15/749168 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11418996 [patent_doc_number] => 20170027140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'Human SIRPa Transgenic Animals and Their Methods of Use' [patent_app_type] => utility [patent_app_number] => 15/223879 [patent_app_country] => US [patent_app_date] => 2016-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14797 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15223879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13329193 [patent_doc_number] => 20180216134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => PROMOTERS FOR ENHANCING EXPRESSION IN POXVIRUSES [patent_app_type] => utility [patent_app_number] => 15/747844 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11396350 [patent_doc_number] => 20170016886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'INDUCED PLURIPOTENT STEM CELL MODEL OF NOONAN SYNDROME AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/221217 [patent_app_country] => US [patent_app_date] => 2016-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9265 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15221217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12866260 [patent_doc_number] => 20180180595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => CELL LINES MUTANT FOR PATCHED 1 AND PATCHED 2 AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/739933 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13382041 [patent_doc_number] => 20180242562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => BIRDS, METHOD FOR PRODUCING BIRDS, AND BIRD EGGS [patent_app_type] => utility [patent_app_number] => 15/755455 [patent_app_country] => US [patent_app_date] => 2016-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11971440 [patent_doc_number] => 20170275594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS USING SYNTHETIC PEPTIDE' [patent_app_type] => utility [patent_app_number] => 15/514337 [patent_app_country] => US [patent_app_date] => 2016-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4079 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11119759 [patent_doc_number] => 20160316732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'CONTROL AND CHARACTERIZATION OF PSYCHOTIC STATES' [patent_app_type] => utility [patent_app_number] => 15/214402 [patent_app_country] => US [patent_app_date] => 2016-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18453 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15214402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13300725 [patent_doc_number] => 20180201899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => IPSC-EC PERFORMANCE ENHANCEMENT VIA SIRT1 OVEREXPRESSION [patent_app_type] => utility [patent_app_number] => 15/744216 [patent_app_country] => US [patent_app_date] => 2016-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12423360 [patent_doc_number] => 09974288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Method of making polyethylene glycol-modified mammalian erythropoietin in a transgenic chicken [patent_app_type] => utility [patent_app_number] => 15/207850 [patent_app_country] => US [patent_app_date] => 2016-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 12904 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15207850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13106873 [patent_doc_number] => 10072069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-11 [patent_title] => Humanized monoclonal antibodies from a transgenic rat [patent_app_type] => utility [patent_app_number] => 15/206063 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14229 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15206063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12523911 [patent_doc_number] => 10004801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => HBV epitope reactive exogenous T cell receptor (TCR) and uses thereof [patent_app_type] => utility [patent_app_number] => 15/201086 [patent_app_country] => US [patent_app_date] => 2016-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 26 [patent_no_of_words] => 18324 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15201086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11323107 [patent_doc_number] => 20160353718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'PRODUCTION OF TRANSGENIC AVIANS USING IMPROVED RETROVIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 15/181987 [patent_app_country] => US [patent_app_date] => 2016-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12604 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12880813 [patent_doc_number] => 20180185446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => COMPOSITION AND METHOD FOR INDUCING ANTI-APOPTOSIS, SURVIVAL OR PROLIFERATION OF A CELL [patent_app_type] => utility [patent_app_number] => 15/736110 [patent_app_country] => US [patent_app_date] => 2016-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12808675 [patent_doc_number] => 20180161395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 15/580934 [patent_app_country] => US [patent_app_date] => 2016-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17453007 [patent_doc_number] => 11267852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Cell lines for screening odorant and aroma receptors [patent_app_type] => utility [patent_app_number] => 15/580110 [patent_app_country] => US [patent_app_date] => 2016-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 5820 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13531847 [patent_doc_number] => 20180317466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => Mice with Modified Glucose-6-Phosphate Dehydrogenase (G6PD) and Uses Thereof [patent_app_type] => utility [patent_app_number] => 15/578659 [patent_app_country] => US [patent_app_date] => 2016-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3048 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12808624 [patent_doc_number] => 20180161378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => AGENT FOR PROMOTING MIGRATION OF PLURIPOTENT STEM CELLS [patent_app_type] => utility [patent_app_number] => 15/577929 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577929 [rel_patent_id] =>[rel_patent_doc_number] =>)